Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 3, 2012, Pages 474-480

  Bats, Anne Sophie ^a,b,c   Hugonnet, Florent ^a,b   Huchon, Cyrille ^a,b   Bensaid, Chérazade ^b   Pierquet Ghazzar, Nadia ^b   Faraggi, Marc ^a,b   Lécuru, Fabrice ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

Mediastinal 18F FDG uptake; Ovarian cancer; Positron emission tomography computed tomography; Prognosis; Survival

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG TUMOR LEVEL; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MEDIASTINUM; OVARY CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84859637643     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1984-9     Document Type: Article

References (17)

1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248-59. (Pubitemid 34177431)
2. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90(2):390-6. (Pubitemid 36952033)
3. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559-64. (Pubitemid 44602167)
4. Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106:914-22. (Pubitemid 43238460)
5. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110:1738-44. (Pubitemid 47557298)
6. Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography - a prospective study. Gynecol Oncol. 2008;108:265-70. (Pubitemid 351181445)
7. Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber W, et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005;23:7445-53. (Pubitemid 46291806)
8. Nam E, Yun M, Oh Y, Kim J, Kim J, Kim S, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116:389-94.
9. Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol. 2010;116:395-8.
10. Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16 Suppl 1:35-40.
11. Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, Downey R, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol. 2004;94:307-11. (Pubitemid 39024531)
12. Cohen-Mouly S, Badia A, Bats AS, Barthes F, Bensaid C, Riquet M, et al. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion. Int J Gynecol Cancer. 2009;19:1662-5.
13. Kolev V, Mironov S, Mironov O, Ishill N, Moskowitz C, Gardner G, et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:979-84.
14. Souilamas R, Hidden G, Riquet M. Mediastinal lymphatic efferents from the diaphragm. Surg Radiol Anat. 2001;23: 159-62. (Pubitemid 32640674)
15. Okiemy G, Foucault C, Avisse C, Hidden G, Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat. 2003; 25:32-5. (Pubitemid 36833715)
16. Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake - the role of PET/CT. Eur Radiol. 2006;16 (5):1054-65.
17. Lim M, Lee H, Jung D, Choi J, Seo S, Park S. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol. 2009;16:1990-6.